Epidemiology

You have full text access to this OnlineOpen article

Patients with previous cancer should not be excluded in international comparative cancer survival studies

  1. Hermann Brenner1,†,*,
  2. Timo Hakulinen2

Article first published online: 26 JUN 2007

DOI: 10.1002/ijc.22932

Issue

International Journal of Cancer

International Journal of Cancer

Volume 121, Issue 10, pages 2274–2278, 15 November 2007

Additional Information

How to Cite

Brenner, H. and Hakulinen, T. (2007), Patients with previous cancer should not be excluded in international comparative cancer survival studies. Int. J. Cancer, 121: 2274–2278. doi: 10.1002/ijc.22932

Author Information

  1. 1

    Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Bergheimer Strasse 20, D-69115 Heidelberg, Germany

  2. 2

    Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Liisankatu 21 B, FIN-00170 Helsinki, Finland

  1. †

    Fax: +49-6221-548142.

*Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Bergheimer Strasse 20, D-69115 Heidelberg, Germany

Publication History

  1. Issue published online: 25 SEP 2007
  2. Article first published online: 26 JUN 2007
  3. Manuscript Accepted: 21 MAY 2007
  4. Manuscript Received: 9 MAR 2007

Funded by

  • German Cancer Foundation. Grant Number: 70-3166-Br 5
  • Academy of Finland
  • Cancer Society of Finland

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (68K)

References

  • 1
    Capocaccia R, Gatta G, Chessa E, Valente F, the EUROCARE Working Group. The EUROCARE-2 study. In: BerrinoF, CapocacciaR, EstèveJ, GattaG, HakulinenT, MicheliA, SantM, VerdecchiaA, eds. Survival of cancer patients in Europe: the EUROCARE-2 sudy, Lyon (France): IARC Scientific Publications No. 151, 1999.
  • 2
    Capocaccia R, Gatta G, Roazzi P, Carrani E, Santaquilani M, De Angelis R, Tavilla A, the EUROCARE Working Group. The EUROCARE-3 database: methodology of data collection, standardisation, quality control and statistical analysis. Ann Oncol 2003; 14: v14–v27.
  • 3
    Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994; 33: 365–9.
  • 4
    Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Monogr Natl Cancer Inst 1961; 6: 101–21.
  • 5
    Henson DE, Ries LA. The relative survival rate. Cancer 1995; 76: 1687–8.
    Direct Link:
  • 6
    Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982; 38: 933–42.
  • 7
    Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004; 40: 2307–16.
  • 8
    Brenner H, Arndt V, Gefeller O, Hakulinen T. An alternative approach to age adjustment of cancer survival rates. Eur J Cancer 2004; 40: 2317–22.
  • 9
    Brenner H, Hakulinen T, Gefeller O. Computational realization of period analysis for monitoring cancer patient survival. Epidemiology 2002; 13: 611–2.
  • 10
    Arndt V, Talbäck M, Gefeller O, Hakulinen T. Modification of SAS macros for more efficient analysis of relative survival rates. Eur J Cancer 2004; 40: 778–9.
View Full Article (HTML) Get PDF (68K)